ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/16 | 1,589 | 1,603 | 1,544 | 1,552 | -41 | -2.6% | 620,300 |
2020/12/15 | 1,610 | 1,617 | 1,546 | 1,593 | -27 | -1.7% | 1,074,700 |
2020/12/14 | 1,617 | 1,640 | 1,609 | 1,620 | -10 | -0.6% | 304,400 |
2020/12/11 | 1,656 | 1,656 | 1,616 | 1,630 | +9 | +0.6% | 497,100 |
2020/12/10 | 1,671 | 1,674 | 1,613 | 1,621 | -59 | -3.5% | 658,000 |
2020/12/09 | 1,641 | 1,690 | 1,616 | 1,680 | +45 | +2.8% | 785,500 |
2020/12/08 | 1,615 | 1,654 | 1,610 | 1,635 | +10 | +0.6% | 565,300 |
2020/12/07 | 1,680 | 1,680 | 1,598 | 1,625 | -47 | -2.8% | 892,300 |
2020/12/04 | 1,669 | 1,675 | 1,636 | 1,672 | -5 | -0.3% | 754,700 |
2020/12/03 | 1,704 | 1,710 | 1,670 | 1,677 | -23 | -1.4% | 755,300 |
2020/12/02 | 1,712 | 1,782 | 1,670 | 1,700 | +55 | +3.3% | 3,189,700 |
2020/12/01 | 1,592 | 1,656 | 1,592 | 1,645 | +63 | +4% | 1,081,700 |
2020/11/30 | 1,589 | 1,602 | 1,544 | 1,582 | +15 | +1% | 803,000 |
2020/11/27 | 1,556 | 1,595 | 1,555 | 1,567 | -8 | -0.5% | 694,000 |
2020/11/26 | 1,519 | 1,585 | 1,506 | 1,575 | +52 | +3.4% | 1,211,900 |
2020/11/25 | 1,482 | 1,527 | 1,460 | 1,523 | +47 | +3.2% | 919,700 |
2020/11/24 | 1,525 | 1,534 | 1,446 | 1,476 | -37 | -2.4% | 3,451,500 |
2020/11/20 | 1,382 | 1,636 | 1,382 | 1,513 | +119 | +8.5% | 9,775,700 |
2020/11/19 | 1,440 | 1,440 | 1,389 | 1,394 | -46 | -3.2% | 437,000 |
2020/11/18 | 1,428 | 1,447 | 1,410 | 1,440 | +2 | +0.1% | 300,900 |
2020/11/17 | 1,470 | 1,481 | 1,423 | 1,438 | -42 | -2.8% | 568,900 |
2020/11/16 | 1,453 | 1,496 | 1,443 | 1,480 | +41 | +2.8% | 769,000 |
2020/11/13 | 1,411 | 1,466 | 1,409 | 1,439 | +14 | +1% | 650,200 |
2020/11/12 | 1,423 | 1,436 | 1,404 | 1,425 | -48 | -3.3% | 867,400 |
2020/11/11 | 1,439 | 1,488 | 1,437 | 1,473 | +45 | +3.2% | 994,700 |
2020/11/10 | 1,430 | 1,470 | 1,412 | 1,428 | +28 | +2% | 1,230,000 |
2020/11/09 | 1,424 | 1,424 | 1,380 | 1,400 | -7 | -0.5% | 505,300 |
2020/11/06 | 1,389 | 1,433 | 1,380 | 1,407 | +7 | +0.5% | 839,800 |
2020/11/05 | 1,348 | 1,401 | 1,341 | 1,400 | +53 | +3.9% | 1,243,800 |
2020/11/04 | 1,302 | 1,352 | 1,293 | 1,347 | +90 | +7.2% | 1,099,000 |
2020/11/02 | 1,260 | 1,266 | 1,238 | 1,257 | +10 | +0.8% | 541,500 |
2020/10/30 | 1,300 | 1,308 | 1,238 | 1,247 | -69 | -5.2% | 846,600 |
2020/10/29 | 1,276 | 1,317 | 1,270 | 1,316 | +30 | +2.3% | 478,600 |
2020/10/28 | 1,298 | 1,300 | 1,279 | 1,286 | -17 | -1.3% | 384,300 |
2020/10/27 | 1,253 | 1,306 | 1,250 | 1,303 | +24 | +1.9% | 551,300 |
2020/10/26 | 1,286 | 1,303 | 1,273 | 1,279 | -6 | -0.5% | 350,300 |
2020/10/23 | 1,271 | 1,294 | 1,253 | 1,285 | +22 | +1.7% | 442,100 |
2020/10/22 | 1,316 | 1,317 | 1,262 | 1,263 | -57 | -4.3% | 794,100 |
2020/10/21 | 1,302 | 1,332 | 1,287 | 1,320 | +19 | +1.5% | 424,700 |
2020/10/20 | 1,327 | 1,328 | 1,293 | 1,301 | -25 | -1.9% | 728,500 |
2020/10/19 | 1,313 | 1,344 | 1,304 | 1,326 | +1 | +0.1% | 385,000 |
2020/10/16 | 1,351 | 1,358 | 1,313 | 1,325 | -25 | -1.9% | 930,500 |
2020/10/15 | 1,365 | 1,383 | 1,350 | 1,350 | -16 | -1.2% | 606,600 |
2020/10/14 | 1,381 | 1,388 | 1,365 | 1,366 | -15 | -1.1% | 471,000 |
2020/10/13 | 1,408 | 1,417 | 1,375 | 1,381 | -21 | -1.5% | 847,600 |
2020/10/12 | 1,392 | 1,422 | 1,379 | 1,402 | +12 | +0.9% | 450,800 |
2020/10/09 | 1,387 | 1,391 | 1,368 | 1,390 | +8 | +0.6% | 373,000 |
2020/10/08 | 1,405 | 1,405 | 1,377 | 1,382 | -15 | -1.1% | 558,000 |
2020/10/07 | 1,394 | 1,414 | 1,390 | 1,397 | -21 | -1.5% | 361,200 |
2020/10/06 | 1,419 | 1,428 | 1,389 | 1,418 | -1 | -0.1% | 543,900 |
1101~
1150
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム